This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Siemens To Donate Hearing Aids Valued At $1M To Cancer Patients

Siemens Hearing Instruments, Inc. today announced partnerships with the Pediatric Brain Tumor Foundation (PBTF) and Cancer Care® to bring top-of-the-line hearing aids and audiology services to cancer patients across the country as part of The Baton Pass™, a grassroots fundraising campaign for Stand Up To Cancer (SU2C). Siemens will donate hearing aids valued at $1M, to be distributed via PBTF and Cancer Care’s network of hospitals to benefit patients with permanent hearing loss due to the side-effects of chemotherapy and/or radiation, surgery or other cancer treatment regimens. The hearing aid donation complements “The Baton Pass™” campaign launched last week, through which Siemens pledged to donate up to $1M in research funds to Stand Up To Cancer for accelerated cancer research.

“Hearing loss significantly affects quality of life—but in many cases can be remedied. We are donating our most advanced micon™ hearing aids, including the tiny Pure® receiver-in-the-canal (RIC), waterproof Aquaris™, the comfortable Motion®, and superpower Nitro® behind-the-ear (BTE) to patients who have lost their hearing as a consequence of cancer treatment,” said Scott Davis, CEO, Siemens Hearing Instruments. “Children and adults undergoing treatment have enough to worry about. By partnering with these two recognized organizations and their network of leading cancer institutions, we’re able to provide the gift of hearing to as many patients as possible.”

The donation also aims to raise awareness about the phenomenon of ototoxicity among platinum-based chemotherapy medications, radiation therapy and other regimens used to treat brain, lung, ovarian, and other types of cancers. Although widely successful in treating cancer, these treatments may also damage healthy cochlear hair cells found in the inner ear—often resulting in irreversible hearing loss.

“Cancer treatment side effects can drastically alter a person’s life and present tremendous physical, emotional and practical challenges,” said Cancer Care Chief Program and Communications Officer Brian Tomlinson, MPA, BSW. “Our clients will now be better able to cope with one of the most devastating treatment side-effects—hearing loss—thanks to the generosity of Siemens and the commitment of MD Anderson Cancer Center. We commend Siemens for their pledge to provide a higher quality of care for people living with cancer and for raising ototoxicity awareness.”

The effects of ototoxicity and hearing loss are well documented. Left untreated, hearing loss has been associated with a variety of conditions in both adults and children. Adult hearing loss has been linked to cognitive decline, depression, dementia, heart disease and diabetes. In children, untreated hearing loss may result in poor cognitive and psychosocial development and delayed or compromised speech and language skills.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs